查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1429521

2024 年介入性腫瘤設備全球市場報告

Interventional Oncology Devices Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

介入腫瘤設備的市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 6.7% 的複合年成長率 (CAGR) 成長至 32.5 億美元。預測期內的預期成長是由於老年人口增加、對微創手術（MIS）的偏好增加、研發支出增加、醫療保健支出增加、新興經濟體的巨大潛力以及經濟成長。這可能是由於等因素。癌症和慢性病的發生率增加。預測期內預期的顯著趨勢包括重點開發先進的影像引導腫瘤治療設備、利用人工智慧（AI）創建創新設備以及利用人工智慧（AI）增強腫瘤治療。和創新的栓塞設備以及對機器人技術的使用的重視。利用技術並與其他公司和研究機構合作，加速產品開發和創新。

由於私人和政府來源的資金的可用性，介入腫瘤設備市場見證了成長。增加對癌症研究的資助，特別是治療中使用的設備，將有助於早期檢測的進步和提高存活率。主要的非政府癌症研究資助者美國癌症協會在 2021 年為 630 個計劃津貼384,262,652 美元。一個著名的資金籌措例子是 BioProtect Ltd.，這是一家為前列腺癌患者開發生物可吸收聚合物間隔球囊的以色列公司，該公司獲得了來自創業投資人，獲得了 1300 萬美元。此外，第一個擴增實境引導消融系統 Endosight 的 20% 資金來自私人組織。這些資金籌措舉措將促進創新技術和設備的發展，進而推動介入腫瘤設備市場。

由於癌症的高發生率，介入腫瘤設備市場可望成長。癌症以不受控制的細胞增殖為特徵，對用於診斷、治療和管理的介入性腫瘤設備產生了巨大的需求。例如，麥克米倫癌症支持組織估計，2020 年將有300 萬人患有癌症，預計到2025 年將增至350 萬人，到2030 年將增至400 萬人，到2040 年將增至530 萬人。癌症盛行率的上升是介入腫瘤設備市場的關鍵驅動力。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長，2023-2028、2033

第6章市場區隔

  • 全球介入性腫瘤設備市場，依產品細分、實際及預測，2018-2023、2023-2028、2033
  • 栓塞裝置
  • 消融裝置
  • 支撐裝置
  • 全球介入性腫瘤設備市場，按程序、性能和預測細分，2018-2023、2023-2028、2033
  • 腫瘤熱消融術
  • 非熱腫瘤消融
  • 經導管動脈化療栓塞術（TACE）
  • 經導管動脈放射栓塞 (TARE) 或選擇性體內放射治療 (SIRT)
  • 經導管動脈栓塞 (TAE) 或品牌栓塞
  • 全球介入性腫瘤器材市場，依癌症類型、表現和預測細分，2018-2023、2023-2028、2033
  • 肝癌
  • 腎癌
  • 肺癌
  • 骨癌
  • 其他癌症類型

第 7 章 區域與國家分析

  • 全球介入性腫瘤設備市場，按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球介入性腫瘤設備市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 介入性腫瘤器材市場競爭形勢
  • 介入性腫瘤設備市場公司概況
    • Boston Scientific Corporation
    • Terumo Corporation
    • Siemens Healthineers
    • Sirtex Medical Limited
    • Merit Medical Systems, Inc.

第31章 其他大型創新公司

  • Merck &Co. Inc.
  • CVS Health
  • Henlius
  • Viant Medical
  • AngioDynamics Inc.
  • Pfizer
  • Steris Applied Sterilization Technologies
  • Co, Dr.Reddy's
  • International SOS
  • CapeRay
  • Innovent Biologics
  • Novartis AG
  • Consonance
  • ABLbio
  • Adimmune

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r14492

Interventional oncology devices are utilized in the diagnosis and treatment of cancer through minimally invasive techniques and advanced imaging technology.

The primary products within the field of interventional oncology devices include embolization devices, ablation devices, and support devices. Embolization devices are designed for the embolization of blood vessels associated with various tumors. These devices are employed in procedures such as thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE), selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE) or bland embolization. These procedures are applied in the treatment of various cancer types, including liver cancer, kidney cancer, lung cancer, bone cancer, and others.

The interventional oncology devices market research report is one of a series of new reports from The Business Research Company that provides interventional oncology devices market statistics, including interventional oncology devices industry global market size, regional shares, competitors with a interventional oncology devices market share, detailed interventional oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the interventional oncology devices industry. This interventional oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional oncology devices market size has grown strongly in recent years. It will grow from $2.35 billion in 2023 to $2.5 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The expansion observed in the historical period can be attributed to factors such as an aging population pool, an increase in cancer prevalence, an uptick in pharmaceutical research and development (R&D) expenditure, increased healthcare expenditure, and growth in the number of healthcare facilities.

The interventional oncology devices market size is expected to see strong growth in the next few years. It will grow to $3.25 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated growth in the forecast period can be attributed to factors such as the increasing older population, a growing preference towards minimally invasive surgeries (MIS), escalating research and development spending, a rise in healthcare expenditure, high potential in emerging economies, and an increasing prevalence of cancer and chronic diseases. Notable trends expected in the forecast period include a focus on developing advanced image-guided oncology devices, the utilization of artificial intelligence (AI) to create innovative devices, the development of new and innovative embolic devices to enhance oncology procedures, an emphasis on using robotics technology, and collaboration with other companies and research institutes to accelerate product development and innovation.

The interventional oncology devices market has experienced growth driven by the availability of funding from both private and government sources. Increased funding in cancer research, especially for devices used in treatments, contributes to advancements in early detection and improved survival rates. In 2021, the American Cancer Society, a major non-governmental cancer research funder, allocated $384,262,652 in grants to 630 projects. Notable funding examples include BioProtect Ltd., an Israeli company developing bioabsorbable polymer spacer balloons for prostate cancer patients, which received $13 million in Series D equity financing from venture investors. Additionally, Endosight, the first augmented-reality-guided ablative system, secured 20% of its funding from private organizations. These funding initiatives foster the development of innovative technologies and devices, thereby propelling the interventional oncology devices market.

The interventional oncology devices market is poised for growth due to the high prevalence of cancer. Cancer, characterized by uncontrolled cell growth, creates a substantial demand for interventional oncology devices used in diagnosis, treatment, and management. For instance, Macmillan Cancer Support estimated 3 million people with cancer in 2020, projecting an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. This heightened prevalence of cancer is a significant driver for the interventional oncology devices market.

Companies in the interventional oncology devices market are increasingly incorporating robotics technology to enhance efficiency. Robotic systems integrate image-based planning and navigation, allowing accurate and efficient installation of instruments to specific body parts. In March 2022, the U.S. Food and Drug Administration approved Quantum Surgical's Epione interventional oncology robotics platform, showcasing the industry's commitment to technological advancements.

Major players in the interventional oncology devices market are focused on innovation, such as AI-powered digital pathology solutions, to enhance the accuracy of breast cancer diagnosis. Paige AI Inc., a U.S.-based biotechnology company, launched Paige Breast Lymph Node in March 2022, an AI-powered digital pathology solution improving the detection of breast cancer metastases in lymph node tissue. This technology offers AI-driven detection capabilities, a convenient heat map overlay, high sensitivity and specificity, seamless integration into existing workflows, user-friendliness, and robust security measures.

In August 2022, Boston Scientific Corporation acquired Obsidio Inc. for an undisclosed amount, aiming to expand its interventional oncology portfolio and strengthen its position in the growing market. Obsidio Inc., a U.S.-based medical device company, specializes in developing minimally invasive interventional oncology devices for treating liver cancer and other solid tumors.

Major companies operating in the interventional oncology devices market report are Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Merit Medical Systems, Inc., Merck & Co. Inc., CVS Health, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, CoDr.Reddys, International SOS, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic PLC, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc., Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International

North America was the largest region in the interventional oncology devices market in 2023. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the interventional oncology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The interventional oncology devices market consists of sales of embolization devices, ablation devices, and support devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Oncology Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional oncology devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional oncology devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Embolization Devices; Ablation Devices; Support Devices
  • 2) By procedure: Thermal Tumor Ablation; Non-Thermal Tumor Ablation; Transcatheter Arterial Chemoembolization (TACE); Transcatheter Arterial Radioembolization (TARE); Selective Internal Radiation Therapy (SIRT); Transcatheter Arterial Embolization (TAE); Bland Embolization
  • 3) By Cancer Type: Liver Cancer; Kidney Cancer; Lung Cancer; Bone Cancer; Other Cancer Types
  • Companies Mentioned: Boston Scientific Corporation; Terumo Corporation; Siemens Healthineers; Sirtex Medical Limited; Merit Medical Systems, Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Oncology Devices Market Characteristics

3. Interventional Oncology Devices Market Trends And Strategies

4. Interventional Oncology Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Interventional Oncology Devices Market Size and Growth

  • 5.1. Global Interventional Oncology Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Interventional Oncology Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Interventional Oncology Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Interventional Oncology Devices Market Segmentation

  • 6.1. Global Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Embolization Devices
  • Ablation Devices
  • Support Devices
  • 6.2. Global Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Thermal Tumor Ablation
  • Non-thermal Tumor Ablation
  • Transcatheter Arterial Chemoembolization (TACE)
  • Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT)
  • Transcatheter Arterial Embolization (TAE) or Bland Embolization
  • 6.3. Global Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Liver Cancer
  • Kidney Cancer
  • Lung Cancer
  • Bone Cancer
  • Other Cancer Types

7. Interventional Oncology Devices Market Regional And Country Analysis

  • 7.1. Global Interventional Oncology Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Interventional Oncology Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Interventional Oncology Devices Market

  • 8.1. Asia-Pacific Interventional Oncology Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Interventional Oncology Devices Market

  • 9.1. China Interventional Oncology Devices Market Overview
  • 9.2. China Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Interventional Oncology Devices Market

  • 10.1. India Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Interventional Oncology Devices Market

  • 11.1. Japan Interventional Oncology Devices Market Overview
  • 11.2. Japan Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Interventional Oncology Devices Market

  • 12.1. Australia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Interventional Oncology Devices Market

  • 13.1. Indonesia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Interventional Oncology Devices Market

  • 14.1. South Korea Interventional Oncology Devices Market Overview
  • 14.2. South Korea Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Interventional Oncology Devices Market

  • 15.1. Western Europe Interventional Oncology Devices Market Overview
  • 15.2. Western Europe Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Interventional Oncology Devices Market

  • 16.1. UK Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Interventional Oncology Devices Market

  • 17.1. Germany Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Interventional Oncology Devices Market

  • 18.1. France Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Interventional Oncology Devices Market

  • 19.1. Italy Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Interventional Oncology Devices Market

  • 20.1. Spain Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Interventional Oncology Devices Market

  • 21.1. Eastern Europe Interventional Oncology Devices Market Overview
  • 21.2. Eastern Europe Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Interventional Oncology Devices Market

  • 22.1. Russia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Interventional Oncology Devices Market

  • 23.1. North America Interventional Oncology Devices Market Overview
  • 23.2. North America Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Interventional Oncology Devices Market

  • 24.1. USA Interventional Oncology Devices Market Overview
  • 24.2. USA Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Interventional Oncology Devices Market

  • 25.1. Canada Interventional Oncology Devices Market Overview
  • 25.2. Canada Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Interventional Oncology Devices Market

  • 26.1. South America Interventional Oncology Devices Market Overview
  • 26.2. South America Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Interventional Oncology Devices Market

  • 27.1. Brazil Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Interventional Oncology Devices Market

  • 28.1. Middle East Interventional Oncology Devices Market Overview
  • 28.2. Middle East Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Interventional Oncology Devices Market

  • 29.1. Africa Interventional Oncology Devices Market Overview
  • 29.2. Africa Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Interventional Oncology Devices Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Oncology Devices Market Competitive Landscape
  • 30.2. Interventional Oncology Devices Market Company Profiles
    • 30.2.1. Boston Scientific Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Terumo Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sirtex Medical Limited
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Merit Medical Systems, Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Interventional Oncology Devices Market Other Major And Innovative Companies

  • 31.1. Merck & Co. Inc.
  • 31.2. CVS Health
  • 31.3. Henlius
  • 31.4. Viant Medical
  • 31.5. AngioDynamics Inc.
  • 31.6. Pfizer
  • 31.7. Steris Applied Sterilization Technologies
  • 31.8. Co, Dr.Reddy's
  • 31.9. International SOS
  • 31.10. CapeRay
  • 31.11. Innovent Biologics
  • 31.12. Novartis AG
  • 31.13. Consonance
  • 31.14. ABLbio
  • 31.15. Adimmune

32. Global Interventional Oncology Devices Market Competitive Benchmarking

33. Global Interventional Oncology Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Interventional Oncology Devices Market

35. Interventional Oncology Devices Market Future Outlook and Potential Analysis

  • 35.1 Interventional Oncology Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Interventional Oncology Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Interventional Oncology Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer